ID
40526
Beschrijving
LOCALIZED PROSTATE CANCER DATA COLLECTION Version 2.0.5 Revised: April 7th , 2017 www.ichom.org Notice: This work was conducted using resources from ICHOM, the International Consortium for Health Outcomes Measurement (www.ICHOM.org). The content is solely the responsibility of the authors and does not necessarily represent the official views of ICHOM. Conditions: Localized prostate cancer Treatment Approaches: Active Surveillance | Watchful Waiting | Radical Prostatectomy* | External Beam Radiation Therapy* | Androgen Deprivation Therapy (ADT)* | Focal Therapy* | Other* * These should also be collected as salvage treatments where necessary This ODM-file contains Baseline Patient-reported Form. To be used at baseline, i.e., post-diagnosis, pre-treatment. Excluding the Patient Reported Outcome questionnaires (separate form, as asked at multiple timepoints). Please timestamp all variables. Some Standard Set variables are collected at multiple timepoints, and we will ask you to submit these variables in a concatenated VARIABLEID_TIMESTAMP form for future analyses. TEST StudyFor example, VARIABLEID_BASE (baseline); VARIABLEID_6MO (6 month follow-up); VARIABLEID_1YR (1 year follow-up), etc. Survey used: Expanded Prostate Cancer Index Composite (EPIC-26): The EPIC-26 is free for all health care organizations, and a license is not needed. The scoring guide may be found at http://www.med.umich.edu/urology/research/EPIC/EPIC-26-Scoring-1.2007.pdf ; Wei J, Dunn R, Litwin M, Sandler H, and Sanda M. "Development and Validation of the Expanded Prostate Cancer Index Composite (EPIC) for Comprehensive Assessment of Health-Related Quality of Life in Men with Prostate Cancer", Urology. 56: 899-905, 2000. For registries choosing to implement the EPIC-CP rather than the EPIC-26, we recommend using the same variable IDs as the corresponding EPIC-26 questions. This means that only questions 2, 3, 4a, 4b, 4d, 4e, 5, 6e, 6b, 7, 8b, 9, 12, 13a, 13c, and 13d of the EPIC-26 are administered. Utilization of Sexual Medications/Devices: The Utilization of Sexual Medications/Devices is free for all health care organizations, and a license is not needed. Refer to http://dx.doi.org/10.1016/j.urology.2006.01.077 for more information European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ- PR25): The EORTC QLQ-PR25 is free for all health care organizations, but a license is needed for use. Therefore it will not be integrated in this Version of the questionnaire. For more information, please visit http://groups.eortc.be/qol/eortc-qlq-c30 . ICHOM was supported for the Localized Prostate Cancer Standard Set by the Movember Foundation. Publication: Martin NE, Massey L, Stowell C, et al. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015;67(3):460‐467. doi:10.1016/j.eururo.2014.08.075 For this version of the standard set, semantic annotation with UMLS CUIs has been added.
Link
Trefwoorden
Versies (2)
- 21-08-18 21-08-18 - Sarah Riepenhausen
- 30-04-20 30-04-20 - Sarah Riepenhausen
Houder van rechten
ICHOM
Geüploaded op
30 april 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
ICHOM Localized Prostate Cancer
Baseline Patient-reported Form
- StudyEvent: ODM
Beschrijving
Patient Factors
Alias
- UMLS CUI-1
- C1955348
Beschrijving
INCLUSION CRITERIA: All patients TIMING: Before treatment REPORTING SOURCE: Clinical or patient-reported TYPE: Date by DD/MM/YYYY RESPONSE OPTIONS: DD/MM/YYYY
Datatype
date
Alias
- UMLS CUI [1]
- C0001779
- UMLS CUI [2]
- C0421451
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C1298908
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0018799
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0020538
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C1306889
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0024115
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0011849
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0022658
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0023895
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0038454
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0027765
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C1707251
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0011581
Beschrijving
INCLUSION CRITERIA: All patients Based upon the Self-administered Comorbidity Questionnaire (Sangha et al, 2003) TIMING: Before treatment REPORTING SOURCE: patient-reported TYPE: Multiple Answer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0003864
Similar models
Baseline Patient-reported Form
- StudyEvent: ODM
C0421451 (UMLS CUI [2])
C1298908 (UMLS CUI [1,2])
C0018799 (UMLS CUI [1,2])
C0020538 (UMLS CUI [1,2])
C1306889 (UMLS CUI [1,2])
C0024115 (UMLS CUI [1,2])
C0011849 (UMLS CUI [1,2])
C0022658 (UMLS CUI [1,2])
C0023895 (UMLS CUI [1,2])
C0038454 (UMLS CUI [1,2])
C0027765 (UMLS CUI [1,2])
C1707251 (UMLS CUI [1,2])
C0011581 (UMLS CUI [1,2])
C0003864 (UMLS CUI [1,2])